                               SEQUENCE LISTING

<110> MILLER, PAUL LEVI
      CORRAL, LAURA
 
<120> LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS 
      AND METHODS OF USE

<130> 12248-701.200

<140> 13/839,041
<141> 2013-03-15

<160> 40    

<170> PatentIn version 3.5

<210> 1
<211> 353
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
gggatattgt gctcacccaa actcacaaat tcatgtccac atcagtagga gacagggtca       60

acatcacctg caaggccagt caggatgtga atactgctgt agcctggtat caacaaaaac      120

cagggcaatc tcctaaacta ctgattaagt gggcatccac ccggcacact ggagtccctg      180

atcgcttcac aggcagtgga tctgggacag attatatttt caccatcagc agtgtgcagg      240

ctgaagacct ggcactttat tactgtcagc aacattatag cactccgtgg acgttcggtg      300

gaggcaccaa gctggaaatc aaacgggctg atgctgcacc aactgtatcc acc             353


<210> 2
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Asp Ile Val Leu Thr Gln Thr His Lys Phe Met Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Asn Ile Thr Cys Lys Ala Ser Gln Asp Val Asn Thr Ala 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile 
        35                  40                  45              


Lys Trp Ala Ser Thr Arg His Thr Gly Val Pro Asp Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Tyr Ile Phe Thr Ile Ser Ser Val Gln Ala 
65                  70                  75                  80  


Glu Asp Leu Ala Leu Tyr Tyr Cys Gln Gln His Tyr Ser Thr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Asp Ala Ala 
            100                 105                 110         


Pro Thr Val Ser Thr 
        115         


<210> 3
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Lys Ala Ser Gln Asp Val Asn Thr Ala Val Ala 
1               5                   10      


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Trp Ala Ser Thr Arg His Thr 
1               5           


<210> 5
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gln Gln His Tyr Ser Thr Pro Trp Thr 
1               5                   


<210> 6
<211> 399
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 6
cttccggagg tgaagctgga ggagtctgga cctgagctga agaagcctgg agagacagtc       60

aagatctcct gcaaggcttc tggttatacc ttcacagact attcagtgca ctgggtgaag      120

caggctccag gaaagggttt aaagtggatg ggctggataa acactgacac tggtgagcca      180

acatttgcag atgacttcaa gggacggttt gccttctctt tggaaacctc taccagcact      240

gcctatttgc agatcaacaa cctcaaaaat gaggacacgg ctacatattt ctgtgctagg      300

ggagataact acctatatta ctatactatg gactactggg gtcaaggaat atcagtcacc      360

gtctcctcag ccaaaacgac acccccatct gtctattcc                             399


<210> 7
<211> 133
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
Leu Pro Glu Val Lys Leu Glu Glu Ser Gly Pro Glu Leu Lys Lys Pro 
1               5                   10                  15      


Gly Glu Thr Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr 
            20                  25                  30          


Asp Tyr Ser Val His Trp Val Lys Gln Ala Pro Gly Lys Gly Leu Lys 
        35                  40                  45              


Trp Met Gly Trp Ile Asn Thr Asp Thr Gly Glu Pro Thr Phe Ala Asp 
    50                  55                  60                  


Asp Phe Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Thr Ser Thr 
65                  70                  75                  80  


Ala Tyr Leu Gln Ile Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr Tyr 
                85                  90                  95      


Phe Cys Ala Arg Gly Asp Asn Tyr Leu Tyr Tyr Tyr Thr Met Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Ile Ser Val Thr Val Ser Ser Ala Lys Thr Thr Pro 
        115                 120                 125             


Pro Ser Val Tyr Ser 
    130             


<210> 8
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gly Tyr Thr Phe Thr Asp Tyr Ser Val His 
1               5                   10  


<210> 9
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Trp Ile Asn Thr Asp Thr Gly Glu Pro Thr Phe Ala Asp Asp Phe Lys 
1               5                   10                  15      


Gly 
    


<210> 10
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Gly Asp Asn Tyr Leu Tyr Tyr Tyr Thr Met Asp Tyr 
1               5                   10          


<210> 11
<211> 365
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 11
gggatattgt gatgacccaa actccagctt ctttggctgt gtctctaggg cagagggcca       60

ccatctcctg cagagccagc gaaagtgttg ataattatgg cattagtttt atgcactggt      120

tccaacagaa accaggacag ccacccaaac tcctcatcta tgctgcatcc aaccaaggat      180

ccggggtccc tgccaggttt agtggcagtg ggtctgggac agacttcagc ctcaacatcc      240

atcctatgga ggaggatgat actgcaatgt atttctgtca gcaaagtaag gaggttccat      300

tcacgttcgg ctcggggaca aagttggaaa taaaacgggc tgatgctgca ccaactgtat      360

ccacc                                                                  365


<210> 12
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
Asp Ile Val Met Thr Gln Thr Pro Ala Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Gln Arg Ala Thr Ile Ser Cys Arg Ala Ser Glu Ser Val Asp Asn Tyr 
            20                  25                  30          


Gly Ile Ser Phe Met His Trp Phe Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Ala Ala Ser Asn Gln Gly Ser Gly Val Pro Ala 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ser Leu Asn Ile His 
65                  70                  75                  80  


Pro Met Glu Glu Asp Asp Thr Ala Met Tyr Phe Cys Gln Gln Ser Lys 
                85                  90                  95      


Glu Val Pro Phe Thr Phe Gly Ser Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 110         


Ala Asp Ala Ala Pro Thr Val Ser Thr 
        115                 120     


<210> 13
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Arg Ala Ser Glu Ser Val Asp Asn Tyr Gly Ile Ser Phe Met His 
1               5                   10                  15  


<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ala Ala Ser Asn Gln Gly Ser 
1               5           


<210> 15
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Gln Gln Ser Lys Glu Val Pro Phe Thr 
1               5                   


<210> 16
<211> 405
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 16
cttccggagg tacagctgga gcagtcagga cctgaactgg tgaagcctgg ggcttcagtg       60

aagatatcct gcaagacttc tggatacaca ttcactgaat acaccatgca ctgggtgaaa      120

cagagccatg gaaagagccc tgagtggatt ggaggtatta atcctaacaa tggttatgct      180

aggtacaacc agaagttcaa gggcaaggcc acattgactg tagacaagtc ctccagcaca      240

gcctccatgg agctccgcag cctgacatct gaggattctg cagtctgtta ctgtgcaaga      300

gggccctatt actacggtag tagccactat gctatggact actggggtca aggaacctca      360

gtcaccgtct cctcagccaa aacgacaccc ccatctgtct attcc                      405


<210> 17
<211> 135
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 17
Leu Pro Glu Val Gln Leu Glu Gln Ser Gly Pro Glu Leu Val Lys Pro 
1               5                   10                  15      


Gly Ala Ser Val Lys Ile Ser Cys Lys Thr Ser Gly Tyr Thr Phe Thr 
            20                  25                  30          


Glu Tyr Thr Met His Trp Val Lys Gln Ser His Gly Lys Ser Pro Glu 
        35                  40                  45              


Trp Ile Gly Gly Ile Asn Pro Asn Asn Gly Tyr Ala Arg Tyr Asn Gln 
    50                  55                  60                  


Lys Phe Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr 
65                  70                  75                  80  


Ala Ser Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Cys 
                85                  90                  95      


Tyr Cys Ala Arg Gly Pro Tyr Tyr Tyr Gly Ser Ser His Tyr Ala Met 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Ser Val Thr Val Ser Ser Ala Lys Thr 
        115                 120                 125             


Thr Pro Pro Ser Val Tyr Ser 
    130                 135 


<210> 18
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Gly Tyr Thr Phe Thr Glu Tyr Thr Met His 
1               5                   10  


<210> 19
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Gly Ile Asn Pro Asn Asn Gly Tyr Ala Arg Tyr Asn Gln Lys Phe Lys 
1               5                   10                  15      


Gly 
    


<210> 20
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Gly Pro Tyr Tyr Tyr Gly Ser Ser His Tyr Ala Met Asp Tyr 
1               5                   10                  


<210> 21
<211> 368
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 21
gggatattgt gatgacccaa actccactca ctttgtcggt taccattgga caaccagcct       60

ctatttcttg caagtcaagt cagagcctct tatatattaa tggaaaaacc tatttgaatt      120

ggttattaca gaggccaggc cagtctccaa agcgcctaat ctatctggtg tctaaactgg      180

actctggagt ccctgacagg ttcactggca gtggatcggg aacagatttt acactgaaaa      240

tcagcagagt ggaggctgag gatttgggaa tttattactg cgtgcaaggt acacattttc      300

cattcacgtt cggctcgggg acaaagttgg aaataaaacg ggctgatgct gcaccaactg      360

tatccacc                                                               368


<210> 22
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 22
Asp Ile Val Met Thr Gln Thr Pro Leu Thr Leu Ser Val Thr Ile Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Tyr Ile 
            20                  25                  30          


Asn Gly Lys Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Ile Tyr Tyr Cys Val Gln Gly 
                85                  90                  95      


Thr His Phe Pro Phe Thr Phe Gly Ser Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg Ala Asp Ala Ala Pro Thr Val Ser Thr 
        115                 120         


<210> 23
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Lys Ser Ser Gln Ser Leu Leu Tyr Ile Asn Gly Lys Thr Tyr Leu Asn 
1               5                   10                  15      


<210> 24
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Leu Val Ser Lys Leu Asp Ser 
1               5           


<210> 25
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Val Gln Gly Thr His Phe Pro Phe Thr 
1               5                   


<210> 26
<211> 384
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide


<220>
<221> modified_base
<222> (363)..(363)
<223> a, c, t, g, unknown or other

<400> 26
cttccgcaag taaagctgga ggagtctgga cctgagctgg tgaagcctgg agcttcaatg       60

cagatatcct gcaaggcttc tggttactca ttcactgtct acaccatgaa ctgggtgaag      120

cagagccatg gaaagaacct tgagtgggtt ggacttatta atcctttcaa tggtgatact      180

acttacaacc agaagttcaa gggcaaggcc acattaactg tagacaagtc atccagcaca      240

gcctacatgg acctcctcag tctgacatct gacgactctg cagtctatta ctgtgtaaga      300

ttttgggaag gaattgactt ctggggccaa ggcaccactc tcacagtctc ctcagccaaa      360

acnacacccc catctgtcta ttcc                                             384


<210> 27
<211> 128
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 27
Leu Pro Gln Val Lys Leu Glu Glu Ser Gly Pro Glu Leu Val Lys Pro 
1               5                   10                  15      


Gly Ala Ser Met Gln Ile Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr 
            20                  25                  30          


Val Tyr Thr Met Asn Trp Val Lys Gln Ser His Gly Lys Asn Leu Glu 
        35                  40                  45              


Trp Val Gly Leu Ile Asn Pro Phe Asn Gly Asp Thr Thr Tyr Asn Gln 
    50                  55                  60                  


Lys Phe Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr 
65                  70                  75                  80  


Ala Tyr Met Asp Leu Leu Ser Leu Thr Ser Asp Asp Ser Ala Val Tyr 
                85                  90                  95      


Tyr Cys Val Arg Phe Trp Glu Gly Ile Asp Phe Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Leu Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Ser 
        115                 120                 125             


<210> 28
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Gly Tyr Ser Phe Thr Val Tyr Thr Met Asn 
1               5                   10  


<210> 29
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Leu Ile Asn Pro Phe Asn Gly Asp Thr Thr Tyr Asn Gln Lys Phe Lys 
1               5                   10                  15      


Gly 
    


<210> 30
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Phe Trp Glu Gly Ile Asp Phe 
1               5           


<210> 31
<211> 368
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 31
gggatattgt gctcacccag tctccactca ctttgtcggt taccattgga caaccagcct       60

ctatctcttg caagtcaagt cagagcctct tatatagtaa tggaaaatcc tttttgaatt      120

ggttattaca gaggccaggc cagtctccaa agcgcctaat ctatctggtg tctaaattgg      180

actctggagt ccctgacagg ttcactggct gtggatcagg aaaagatttt acactgaaaa      240

tcagcagagt ggaggctgag gatttgggag tttattactg cgtgcaaggt acacattttc      300

ctcagacgtt cggtggaggc accaagctag aaatcaaacg ggctgatgct gcaccaactg      360

tatccacc                                                               368


<210> 32
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 32
Asp Ile Val Leu Thr Gln Ser Pro Leu Thr Leu Ser Val Thr Ile Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Tyr Ser 
            20                  25                  30          


Asn Gly Lys Ser Phe Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Thr Gly Cys Gly Ser Gly Lys Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Val Gln Gly 
                85                  90                  95      


Thr His Phe Pro Gln Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg Ala Asp Ala Ala Pro Thr Val Ser Thr 
        115                 120         


<210> 33
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Lys Ser Ser Gln Ser Leu Leu Tyr Ser Asn Gly Lys Ser Phe Leu Asn 
1               5                   10                  15      


<210> 34
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Leu Val Ser Lys Leu Asp Ser 
1               5           


<210> 35
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Val Gln Gly Thr His Phe Pro Gln Thr 
1               5                   


<210> 36
<211> 384
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 36
cttccggaag tgcagctgga gcagtcagga cctggcctag tgcagccctc acagagcctg       60

tccatcacct gcacagtctc tggtttctca ttaaccacct atgatgtact ctgggtgcgc      120

cagtctccag gaaagggtct ggagtggctg ggaattatct ggagtggtgg aagcgcagac      180

tataatgcag ctttcatctc cagactgagc atcactaagg acaattccaa gagccaagtt      240

ttctttgaaa tgaacagtct gcaagctaat gacacagcca tatattactg tgccagttac      300

tacatcaatg ctctggacta ctgggggcaa ggaacctcag tcaccgtctc ctcagccaaa      360

acgacacccc catctgtcta ttcc                                             384


<210> 37
<211> 128
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 37
Leu Pro Glu Val Gln Leu Glu Gln Ser Gly Pro Gly Leu Val Gln Pro 
1               5                   10                  15      


Ser Gln Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr 
            20                  25                  30          


Thr Tyr Asp Val Leu Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Leu Gly Ile Ile Trp Ser Gly Gly Ser Ala Asp Tyr Asn Ala Ala 
    50                  55                  60                  


Phe Ile Ser Arg Leu Ser Ile Thr Lys Asp Asn Ser Lys Ser Gln Val 
65                  70                  75                  80  


Phe Phe Glu Met Asn Ser Leu Gln Ala Asn Asp Thr Ala Ile Tyr Tyr 
                85                  90                  95      


Cys Ala Ser Tyr Tyr Ile Asn Ala Leu Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Ser Val Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Ser 
        115                 120                 125             


<210> 38
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Gly Phe Ser Leu Thr Thr Tyr Asp Val Leu 
1               5                   10  


<210> 39
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 39
Ile Ile Trp Ser Gly Gly Ser Ala Asp Tyr Asn Ala Ala Phe Ile Ser 
1               5                   10                  15      


<210> 40
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Tyr Tyr Ile Asn Ala Leu Asp Tyr 
1               5               

